Danaher Corporation today announced the proposed public offering of 6,000,000 shares of its common stock. The public offering will be made pursuant to an effective shelf registration statement on file with the U.S. Securities and Exchange Commission. The proceeds from the proposed public offering will be used to fund, in part, Danaher's pending acquisition of Tektronix, Inc., or for general corporate purposes.

Merrill Lynch & Co. and Morgan Stanley & Co. Incorporated are acting as joint bookrunning managers and Lehman Brothers Inc. and UBS Securities LLC will be acting as co-managers.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, shares of Danaher's common stock or any other securities, nor shall there be any sale of securities mentioned in this press release in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

The offering of common shares may be made only by means of a prospectus and prospectus supplement. A copy of the prospectus and prospectus supplement relating to the securities can be obtained from Merrill Lynch's prospectus department at 4 World Financial Center, New York, NY 10080, telephone: 212- 449-1000, from Morgan Stanley at 180 Varick Street 2/F, New York, NY 10014, email: prospectus@morganstanley.com, telephone: 1-866-718-1649, from Lehman Brothers, c/o Broadridge, Integrated Distribution Services, 1155 Long Island Avenue, Edgewood, NY 11717, email: qiana.smith@broadridge.com, facsimile: 631- 254-7140, from UBS at 299 Park Avenue, New York, NY 10171, telephone: 212-821- 3884.

About Danaher

Danaher Corporation is a leading manufacturer of Professional Instrumentation, Medical Technologies, Industrial Technologies and Tools and Components.

Statements in this document that are not strictly historical, including statements regarding the proposed public offering of common stock, may constitute forward looking statements. There are a number of risks and uncertainties that could cause actual results or events to differ materially from those suggested or indicated by such forward looking statements, including the factors described in Danaher's Annual Report on Form 10-K for the year ended December 31, 2006 and other SEC filings of Danaher. These forward looking statements speak only as of the date of this release and Danaher does not intend to update any forward looking statement except as required by law.

First Call Analyst:
FCMN Contact:

SOURCE: Danaher Corporation